EGBN vs VRTX · rev $258.5M vs P/E 30, rev $3.33B
Eagle Bancorp Inc (EGBN) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Eagle Bancorp Inc (EGBN) is a banks - regional company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported EGBN revenue for 2026-06-30 was $258.5M. Net income was $21.6M. Revenue was up 96.0% from 2026-03-31 to 2026-06-30. EGBN currently screens at market cap $788.3M.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
EGBN currently screens at market cap $788.3M. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the EGBN and VRTX stock pages for the full models.
Not investment advice.